This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01465/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01465/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB01465/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01465/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01465/identifier/pubchem-compound/

Statements

Subject Item
n2:DB01465
rdf:type
n5:Drug
n5:group
illicit experimental
owl:sameAs
n4:DB01465 n7:DB01465
dcterms:title
2,5-Dimethoxyamphetamine
adms:identifier
n9:46507168 n10:DB01465 n11:62787 n12:50005251 n13:56526
n5:IUPAC-Name
n6:271B4D34-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4D3A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4D39-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4D36-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4D37-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4D38-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4D32-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4D49-363D-11E5-9242-09173F13E4C5 n6:271B4D30-363D-11E5-9242-09173F13E4C5 n6:271B4D33-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4D31-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4D40-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4D41-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4D3B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4D3C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4D3E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4D3D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4D3F-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
2801-68-5
n5:Bioavailability
n6:271B4D45-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4D47-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4D48-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4D44-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4D43-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4D46-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4D35-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4D42-363D-11E5-9242-09173F13E4C5